📰 Priority Review Application News
Priority Review Application News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Priority Review Application. Real-time updates on events, politics, business and more.
April 25, 2024
The severity of RSV disease among adults further highlights how crucial vaccine polices and recommendations are.
February 1, 2024
Following the January 25, 2024 approval of dupilumab for eosinophilic esophagitis in patients 1-11 years of age, a trio of pediatric gastroenterologists shares their thoughts on the new indication, their anticipated priority of use, and potential hurdles to optimal treatment uptake.
January 25, 2024
We sat down with Evan Dellon, MD, MPH, to discuss the use of dupilumab in pediatric EoE patients, with the agent gaining FDA approval as the first and only indication for this patient population on January 25, 2024.
January 18, 2023
Lobe Sciences Ltd (CSE:LOBE, OTCQB:LOBED) said it expects to have two active Investigational New Drug applications in progress with the US Food and Drug...